Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CGTX Cognition Therapeutics, Inc

交易中 12-16 11:43:16 EST

1.61

+0.01

+0.31%

最高1.67	最低1.59	成交量28.01万
今开1.60	昨收1.60	日振幅5.00%
总市值1.42亿	流通市值1.41亿	总股本8,827万
成交额45.28万	换手率0.32%	流通股本8,773万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CGTX","market":"US","secType":"STK","nameCN":"Cognition Therapeutics, Inc","latestPrice":1.605,"timestamp":1765903385894,"preClose":1.6,"halted":0,"volume":280125,"delay":0,"floatShares":87726600,"shares":88274258,"eps":-0.455423,"marketStatus":"交易中","change":0.005,"latestTime":"12-16 11:43:16 EST","open":1.6,"high":1.67,"low":1.59,"amount":452790.77253749996,"amplitude":0.05,"askPrice":1.61,"askSize":2297,"bidPrice":1.6,"bidSize":2443,"shortable":3,"etf":0,"ttmEps":-0.455423,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":1.6,"preHourTrading":{"tag":"盘前","latestPrice":1.6002,"preClose":1.6,"latestTime":"09:11 EST","volume":3499,"amount":5646.268419399999,"timestamp":1765894297155},"postHourTrading":{"tag":"盘后","latestPrice":1.65,"preClose":1.6,"latestTime":"19:34 EST","volume":53932,"amount":87360.55,"timestamp":1765845272254},"volumeRatio":0.951804},"requestUrl":"/m/hq/s/CGTX","defaultTab":"news","newsList":[{"id":"1126989645","title":"Cognition Therapeutics提交Zervimesine（Ct1812）在阿尔茨海默病中第三阶段计划于阿尔茨海默病临床试验会议上","url":"https://stock-news.laohu8.com/highlight/detail?id=1126989645","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126989645?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:32","pubTimestamp":1764592329,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics提交Zervimesine（Ct1812）在阿尔茨海默病中第三阶段计划于阿尔茨海默病临床试验会议上","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007"],"gpt_icon":0},{"id":"1186073609","title":"Cognition Therapeutics完成早期阿尔茨海默病Zervimesine（Ct1812）第二阶段研究的招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1186073609","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186073609?lang=zh_cn&edition=full","pubTime":"2025-11-13 20:37","pubTimestamp":1763037431,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics完成早期阿尔茨海默病Zervimesine（Ct1812）第二阶段研究的招募","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"gpt_icon":0},{"id":"1154861692","title":"Cognition Therapeutics Inc - 估计有足够现金支持运营及资本支出至2027年第二季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1154861692","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154861692?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:45","pubTimestamp":1762433132,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics Inc - 估计有足够现金支持运营及资本支出至2027年第二季度","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007"],"gpt_icon":0},{"id":"1108868388","title":"Cognition Therapeutics公布2025年第三季度财务结果，并强调临床项目的进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1108868388","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108868388?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:33","pubTimestamp":1762432437,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics公布2025年第三季度财务结果，并强调临床项目的进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"gpt_icon":0},{"id":"2570442090","title":"Cognition Therapeutics, Inc.盘中异动 下午盘股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570442090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570442090?lang=zh_cn&edition=full","pubTime":"2025-09-26 01:33","pubTimestamp":1758821636,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日01时33分，Cognition Therapeutics, Inc.股票出现异动，股价急速下挫5.19%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.20%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926013357a69e2670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926013357a69e2670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CGTX","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"1100133457","title":"Cognition Therapeutics针对早期阿尔茨海默病的Zervimesine (Ct1812)研究达到75%入组目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1100133457","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100133457?lang=zh_cn&edition=full","pubTime":"2025-09-03 19:32","pubTimestamp":1756899128,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics针对早期阿尔茨海默病的Zervimesine (Ct1812)研究已达到75%的入组目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"gpt_icon":0},{"id":"2555408805","title":"Cognition Therapeutics, Inc.7月28日成交额为498.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555408805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555408805?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:34","pubTimestamp":1753752848,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，Cognition Therapeutics, Inc.成交额为498.79万美元，成交额较昨日增加84.25%，当日成交量为687.58万股。Cognition Therapeutics, Inc.于2025年7月28日跌14.87%，报0.715美元，该股过去5个交易日涨2.16%，年初至今涨2.01%，过去60日涨67.47%。该公司的候选产品CT1812是一种口服小分子拮抗剂，旨在穿透血脑屏障并选择性地与S2R复合物结合。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093649a6c6ca9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093649a6c6ca9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","CGTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2551817291","title":"Cognition Therapeutics, Inc.盘中异动 早盘快速上涨5.75%报0.600美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551817291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551817291?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:30","pubTimestamp":1752499853,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时30分，Cognition Therapeutics, Inc.股票出现波动，股价急速上涨5.75%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421305397a5bc2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421305397a5bc2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CGTX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2550622862","title":"Nautilus Biotechnology, Inc.盘中异动 临近午盘大幅下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550622862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550622862?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:35","pubTimestamp":1752161749,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时35分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅下跌5.20%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Q32 Bio Inc.、Pelthos Therapeutics Inc.、Cognition Therapeutics, Inc.涨幅较大，Cognition Therapeutics, Inc.、Q32 Bio Inc.、Klotho Neurosciences, Inc.较为活跃，换手率分别为353.21%、235.08%、148.99%，振幅较大的相关个股有Q32 Bio Inc.、Cognition Therapeutics, Inc.、Neonc Technologies Holdings, Inc.，振幅分别为90.07%、73.27%、56.89%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710233550a6a1ed64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710233550a6a1ed64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","CGTX","BK4007","BK4121"],"gpt_icon":0},{"id":"2550624033","title":"Cardio Diagnostics Holdings Inc.盘中异动 早盘大幅拉升5.34%报4.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550624033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550624033?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:28","pubTimestamp":1752161302,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时28分，Cardio Diagnostics Holdings Inc.股票出现异动，股价急速上涨5.34%。Cardio Diagnostics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Q32 Bio Inc.、Cognition Therapeutics, Inc.、Pelthos Therapeutics Inc.涨幅较大，Cognition Therapeutics, Inc.、Q32 Bio Inc.、Klotho Neurosciences, Inc.较为活跃，换手率分别为351.62%、217.10%、148.36%，振幅较大的相关个股有Q32 Bio Inc.、Cognition Therapeutics, Inc.、Neonc Technologies Holdings, Inc.，振幅分别为90.07%、73.27%、55.54%。Cardio Diagnostics Holdings Inc.公司简介：Cardio Diagnostics Holdings Inc 是一家医疗技术公司，专注在开发和商业化基于表观遗传学的心血管疾病临床测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023282297a11fbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023282297a11fbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","CDIO","CGTX"],"gpt_icon":0},{"id":"2550130624","title":"Maravai Lifesciences Holdings, Inc.盘中异动 大幅拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550130624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550130624?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:17","pubTimestamp":1752160664,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时17分，Maravai Lifesciences Holdings, Inc.股票出现异动，股价大幅上涨5.25%。Maravai Lifesciences Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Maravai Lifesciences Holdings, Inc.公司简介：Maravai LifeSciences Holdings Inc 是一家生命科学公司，提供关键产品，推动突破性疫苗、药物疗法、细胞和基因疗法以及诊断的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023174497a11d67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023174497a11d67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRVI","CGTX","BK4007","BK4121"],"gpt_icon":0},{"id":"2550915629","title":"Engene Holdings Inc.盘中异动 大幅跳水5.48%报3.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550915629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550915629?lang=zh_cn&edition=full","pubTime":"2025-07-10 22:12","pubTimestamp":1752156744,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日22时12分，Engene Holdings Inc.股票出现异动，股价快速跳水5.48%。截至发稿，该股报3.62美元/股，成交量9533股，换手率0.02%，振幅6.01%。Engene Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710221224a442c6d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710221224a442c6d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGTX","ENGN","BK4007"],"gpt_icon":0},{"id":"2550626401","title":"Gri Bio, Inc.盘中异动 股价大跌5.42%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550626401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550626401?lang=zh_cn&edition=full","pubTime":"2025-07-10 22:04","pubTimestamp":1752156294,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日22时04分，Gri Bio, Inc.股票出现异动，股价急速下挫5.42%。截至发稿，该股报1.57美元/股，成交量3.9736万股，换手率1.69%，振幅4.82%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Gri Bio, Inc.公司简介：GRI Bio Inc是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的疗法，这些疾病包括炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710220454a6a1cbeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710220454a6a1cbeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGTX","GRI","BK4007"],"gpt_icon":0},{"id":"2550625762","title":"珐博进盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550625762","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550625762?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:47","pubTimestamp":1752155252,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时47分，珐博进股票出现波动，股价快速拉升5.01%。截至发稿，该股报6.50美元/股，成交量6915股，换手率0.17%，振幅4.28%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。珐博进股票所在的生物技术行业中，整体跌幅为0.04%。该公司的绝大部分收入来自欧洲，其次是日本。迄今为止，珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710214732953d8673&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710214732953d8673&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4007","CGTX","FGEN"],"gpt_icon":0},{"id":"2550625987","title":"Tnf Pharmaceuticals, Inc.盘中异动 股价大跌5.07%报0.120美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550625987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550625987?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:33","pubTimestamp":1752154402,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时33分，Tnf Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.07%。Tnf Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Cognition Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Cognition Therapeutics, Inc.、Klotho Neurosciences, Inc.、Nucana Plc较为活跃，换手率分别为201.65%、117.99%、59.85%，振幅较大的相关个股有Cognition Therapeutics, Inc.、Neonc Technologies Holdings, Inc.、Nurix Therapeutics, Inc.，振幅分别为26.30%、18.26%、14.42%。Tnf Pharmaceuticals, Inc.公司简介：TNF Pharmaceuticals Inc是一家致力于延长健康寿命的临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071021332397a105ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071021332397a105ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","ACB","BK4007","CGTX","TNFA"],"gpt_icon":0},{"id":"2550625628","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 快速下挫10.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550625628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550625628?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:31","pubTimestamp":1752154310,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时31分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价快速下跌10.01%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体跌幅为0.14%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213150a6a1c13c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213150a6a1c13c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW","CGTX","BK4007"],"gpt_icon":0},{"id":"2550550625","title":"Maia Biotechnology, Inc.盘中异动 快速下挫5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550550625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550550625?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:31","pubTimestamp":1752154309,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时31分，Maia Biotechnology, Inc.股票出现波动，股价快速下跌5.47%。Maia Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Cognition Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Neonc Technologies Holdings, Inc.涨幅较大，Cognition Therapeutics, Inc.、Klotho Neurosciences, Inc.、Nucana Plc较为活跃，换手率分别为195.72%、116.30%、59.26%，振幅较大的相关个股有Nurix Therapeutics, Inc.、Cognition Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为14.42%、13.34%、12.04%。Maia Biotechnology, Inc.公司简介：MAIA Biotechnology Inc 是一家临床阶段的生物制药公司，致力于开发针对癌症的靶向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213150a6a1c139&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213150a6a1c139&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MAIA","BK4139","CGTX"],"gpt_icon":0},{"id":"2550252776","title":"Cel-Sci Corporation盘中异动 早盘大幅拉升8.57%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550252776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550252776?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:31","pubTimestamp":1752154293,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时31分，Cel-Sci Corporation股票出现波动，股价急速上涨8.57%。截至发稿，该股报3.04美元/股，成交量5.157万股，换手率1.00%，振幅2.14%。Cel-Sci Corporation股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Cognition Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Neonc Technologies Holdings, Inc.涨幅较大，Cognition Therapeutics, Inc.、Klotho Neurosciences, Inc.、Nucana Plc较为活跃，换手率分别为194.53%、116.01%、59.08%，振幅较大的相关个股有Nurix Therapeutics, Inc.、Cognition Therapeutics, Inc.、Nextcure, Inc.，振幅分别为13.74%、13.34%、11.47%。Cel-Sci Corporation公司简介：CEL-SCI Corp 是生物技术领域的一家公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213133a6a1c116&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213133a6a1c116&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVM","CGTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2549597663","title":"技术驱动 | 博腾与 Cognition Therapeutics 联合发表 OPRD 论文，彰显药物合成技术实力","url":"https://stock-news.laohu8.com/highlight/detail?id=2549597663","media":"博腾股份Porton","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549597663?lang=zh_cn&edition=full","pubTime":"2025-07-08 14:15","pubTimestamp":1751955353,"startTime":"0","endTime":"0","summary":"近期，Cognition Therapeutics研究团队在美国化学学会权威刊物《Organic Process Research & Development》发表论文《基于光流技术与高通量筛选技术的σ-2受体调节剂CT1812商业化合成路线开发》，博腾股份作为其CDMO合作企业之一，共同参与了此项目。作为工艺化学行业的权威刊物，OPRD在全球化工与制药领域具有广泛影响力，此次是博腾与Cognition Therapeutics首次携手在该期刊发表学术成果，标志着双方在药物合成工艺研发领域的深度合作获得国际学术领域的高度认可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708141645a69c74ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708141645a69c74ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2517100479","title":"Cognition Therapeutics, Inc.盘中异动 早盘股价大跌8.46%报0.385美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517100479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517100479?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185055,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Cognition Therapeutics, Inc.股票出现波动，股价快速跳水8.46%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223055abe9b05a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223055abe9b05a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CGTX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cogrx.com","stockEarnings":[{"period":"1week","weight":-0.0857},{"period":"1month","weight":0.0323},{"period":"3month","weight":-0.0062},{"period":"6month","weight":4.7143},{"period":"1year","weight":2.3473},{"period":"ytd","weight":1.2815}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cognition Therapeutics, Inc.于2007年8月21日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统疾病（CNS）和视网膜的小分子疗法。目前可用于治疗疾病的疗法有限，许多疾病没有获得批准的疗法或治疗方法。该公司的目标是，通过初步利用β-2（SIGMA-2）受体方面的专业知识，为退行性疾病患者开发疾病修饰治疗方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.026933},{"month":2,"riseRate":0,"avgChangeRate":-0.237253},{"month":3,"riseRate":0.25,"avgChangeRate":-0.015618},{"month":4,"riseRate":0.75,"avgChangeRate":-0.007447},{"month":5,"riseRate":0.5,"avgChangeRate":-0.080419},{"month":6,"riseRate":0.25,"avgChangeRate":-0.038614},{"month":7,"riseRate":0.25,"avgChangeRate":0.074037},{"month":8,"riseRate":0.5,"avgChangeRate":0.719491},{"month":9,"riseRate":0,"avgChangeRate":-0.232471},{"month":10,"riseRate":0.5,"avgChangeRate":0.012004},{"month":11,"riseRate":0.2,"avgChangeRate":0.100902},{"month":12,"riseRate":0.4,"avgChangeRate":0.131427}],"exchange":"NASDAQ","name":"Cognition Therapeutics, Inc","nameEN":"Cognition Therapeutics, Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cognition Therapeutics, Inc(CGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cognition Therapeutics, Inc,CGTX,Cognition Therapeutics, Inc股票,Cognition Therapeutics, Inc股票老虎,Cognition Therapeutics, Inc股票老虎国际,Cognition Therapeutics, Inc行情,Cognition Therapeutics, Inc股票行情,Cognition Therapeutics, Inc股价,Cognition Therapeutics, Inc股市,Cognition Therapeutics, Inc股票价格,Cognition Therapeutics, Inc股票交易,Cognition Therapeutics, Inc股票购买,Cognition Therapeutics, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cognition Therapeutics, Inc(CGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}